Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in thedrug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dos ...
Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech along with Suchitra Ella Joint Managing Director, Bharat Biotech, met Professor, Dr Tran Van Thuan, Deputy Minister of Health, Government of the Socialist Republic of Vietnam, in New Del ...
The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years submitted by Bharat Biotech was deliberated in the meeting of the Subject Expert Committee (SEC) on August 28 and October 11, informed Ministry of Healt ...
People will need booster doses of the COVID-19 vaccine would be required if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella. ...
